Intra-Cellular Therapies (ITCI) Director Alafi Buys 125K Shares

September 5, 2019 8:38 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

After the close, Intra-Cellular Therapies (NASDAQ: ITCI) Director Christopher Alafi disclosed he bought 125,000 shares on 08/30 at $8.52.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Insider Trades

Related Entities

The Children's Investment Fund (TCI)